In silico assessment of genotoxicity. Combinations of sensitive structural alerts minimize false negative predictions for all genotoxicity endpoints and can single out chemicals for which experimentation can be avoided

Regul Toxicol Pharmacol. 2021 Sep 7:105042. doi: 10.1016/j.yrtph.2021.105042. Online ahead of print.ABSTRACTGenotoxicity assessment of chemicals has a crucial role in most regulations. Due to labor, time, cost, and animal welfare issues, attention is being given to (Q)SAR methods. A strategic application of alternative methods is to first use a sequence of conservative (very sensitive) (Q)SARs and/or in vitro models to arrive at the conclusion that no further testing is necessary for negatives, and to use mechanistically based, Weight-Of-Evidence approach to evaluate the chemicals showing positive results. The ICH M7 guideline to detect DNA-reactive impurities in drugs follows these lines (recommending solely (Q)SAR in step 1). However, ICH M7 focuses only on Ames test. Here a large database of more than 6000 chemicals positive in at least one endpoint (in vitro gene mutations or chromosomal aberrations, in vivo micronucleus, aneugenicity) were analyzed with structural alerts implemented in the OECD QSAR Toolbox, resulting in maximum 3% false negatives. These promising results indicate that it may be possible to extend the approach to the whole range of genotoxicity endpoints required by regulations. Since structural alerts may generate false positives, cautious follow-up of positives is recommended (with e.g., statistically based QSARs, read across of similar chemicals, expert judgement, and experimentation when necessary).PMID:34506881 | DOI:10.1016/j.yrtph.2021.105042
Source: Regulatory Toxicology and Pharmacology : RTP - Category: Toxicology Authors: Source Type: research